© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
FDA and Industry Not Waiting for Congress on Drug Shortages
Pending legislation in Congress and efforts by the private sector aimed at reducing national drug shortages largely aim to improve communication among manufacturers, distributors, federal regulators, hospitals and physicians to prevent supply problems from arising in the first place.
Reducing drug shortages remains a high priority for congressional leaders. Lawmakers have released three drug shortage bills, and at least one more is in the draft stage. Congressional committees continue to hold regular hearings on the issue. Language on shortages is expected to be included in a reauthorization of the Prescription Drug User Fee Act, which is set to expire at the end of September.